Conduction of a multicentre clinical trial of clonidine in children until the age of 18. Indeed, despite its widespread use in Pediatric Intensive Care Units (PICU), this drug still lacks authorisation for paediatric use. A parenteral age-appropriate formulation of clonidine for sedation in PICU will be developed and tested in order to obtain a Pediatric Use Marketing Authorisation (PUMA).

ROLE OF THE FOUNDATION
The Foundation was partner of the project as involved in regulatory and ethical issues and coordinates the dissemination activities. It also supported the project management.

FUNDED BY: FP7-HEALTH-2013-INNOVATION-1, GA 602453, 2013-18.

DURATION: Dec 2013 - Nov 2018